BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 23728722)

  • 1. Roles of small molecules in somatic cell reprogramming.
    Su JB; Pei DQ; Qin BM
    Acta Pharmacol Sin; 2013 Jun; 34(6):719-24. PubMed ID: 23728722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [From Gurdon to Yamanaka--a brief history of cell reprogramming].
    Kubiak JZ; Ciemerych MA
    Postepy Biochem; 2013; 59(2):124-30. PubMed ID: 24044277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular reprogramming: a small molecule perspective.
    Nie B; Wang H; Laurent T; Ding S
    Curr Opin Cell Biol; 2012 Dec; 24(6):784-92. PubMed ID: 22959962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprogramming rewarded: the 2012 Nobel Prize for Physiology or Medicine awarded to John Gurdon and Shinya Yamanaka.
    Johnson MH; Cohen J
    Reprod Biomed Online; 2012 Dec; 25(6):549-50. PubMed ID: 23211094
    [No Abstract]   [Full Text] [Related]  

  • 5. Chromatin roadblocks to reprogramming 50 years on.
    Skene PJ; Henikoff S
    BMC Biol; 2012 Oct; 10():83. PubMed ID: 23107587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The triumph of chemically enhanced cellular reprogramming: a patent review.
    Anwar MA; Kim S; Choi S
    Expert Opin Ther Pat; 2016; 26(2):265-80. PubMed ID: 26593376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications.
    Sadahiro T; Yamanaka S; Ieda M
    Circ Res; 2015 Apr; 116(8):1378-91. PubMed ID: 25858064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming somatic cells to pluripotency: a fresh look at Yamanaka's model.
    Li Y; Shen Z; Shelat H; Geng YJ
    Cell Cycle; 2013 Dec; 12(23):3594-8. PubMed ID: 24189530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming lineage identity through cell-cell fusion.
    Brown KE; Fisher AG
    Curr Opin Genet Dev; 2021 Oct; 70():15-23. PubMed ID: 34087754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
    J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current status and perspective on regenerative medicine for spinal cord injury using iPS cell].
    Nakamura M; Toyama Y; Okano H
    Rinsho Shinkeigaku; 2013; 53(11):1013-5. PubMed ID: 24291863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic reprogramming of cell identity: lessons from development for regenerative medicine.
    Basu A; Tiwari VK
    Clin Epigenetics; 2021 Jul; 13(1):144. PubMed ID: 34301318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current reprogramming systems in regenerative medicine: from somatic cells to induced pluripotent stem cells.
    Hu C; Li L
    Regen Med; 2016 Jan; 11(1):105-32. PubMed ID: 26679838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced pluripotent stem cells reprogramming: Epigenetics and applications in the regenerative medicine.
    Gomes KM; Costa IC; Santos JF; Dourado PM; Forni MF; Ferreira JC
    Rev Assoc Med Bras (1992); 2017 Feb; 63(2):180-189. PubMed ID: 28355380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small molecules, big roles -- the chemical manipulation of stem cell fate and somatic cell reprogramming.
    Zhang Y; Li W; Laurent T; Ding S
    J Cell Sci; 2012 Dec; 125(Pt 23):5609-20. PubMed ID: 23420199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCNT versus iPSCs: proteins and small molecules in reprogramming.
    Han F; Li X; Song D; Jiang S; Xu Q; Zhang Y
    Int J Dev Biol; 2015; 59(4-6):179-86. PubMed ID: 26505250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of small molecules as drug candidates for reprogramming somatic cells into induced pluripotent stem cells: A comprehensive review.
    Rehman A; Fatima I; Noor F; Qasim M; Wang P; Jia J; Alshabrmi FM; Liao M
    Comput Biol Med; 2024 Jul; 177():108661. PubMed ID: 38810477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprogramming Enhancers in Somatic Cell Nuclear Transfer, iPSC Technology, and Direct Conversion.
    Kwon D; Ji M; Lee S; Seo KW; Kang KS
    Stem Cell Rev Rep; 2017 Feb; 13(1):24-34. PubMed ID: 27817181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.